Petros Pharmaceuticals
PTPI
PTPI was delisted on the 21st of May, 2025.
11 hedge funds and large institutions have $171K invested in Petros Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0.19% → 0.19% (-0%)
8% less funds holding
Funds holding: 12 → 11 (-1)
20% less capital invested
Capital invested by funds: $214K → $171K (-$43.8K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$39.2K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$28.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$34K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$27.4K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.37K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$68 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $55K | – | – | – |
|
|
SSA
2
Schonfeld Strategic Advisors
New York
| $39.3K | -$1.37K | -20 | -2% |
|
3
BlackRock
New York
| $28.6K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $23.7K | +$39.2K | +572 | New |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $17.4K | +$28.8K | +420 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $4.4K | – | – | – |
|
|
EL
7
EMFO LLC
Weston,
Florida
| $1.73K | – | – | – |
|
|
NFSG
8
Newbridge Financial Services Group
Boca Raton,
Florida
| $208 | – | – | – |
|
9
Group One Trading
Chicago,
Illinois
| $131 | – | – | – |
|
10
Morgan Stanley
New York
| $32 | – | – | – |
|
11
Osaic Holdings
Scottsdale,
Arizona
| $24 | – | – | – |
|
12
Wells Fargo
San Francisco,
California
| $19 | – | – | – |
|
13
First Manhattan
New York
| $17 | – | – | – |
|
|
14
Bank of America
Charlotte,
North Carolina
| $2 | -$68 | -1 | Closed |
|
|
15
Renaissance Technologies
New York
| – | -$34K | -671 | Closed |
|
|
16
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$27.4K | -400 | Closed |
|
PTPI Hedge Fund Activity: Q3 2023 in Review
11 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Petros Pharmaceuticals (PTPI) for Q3 2023, worth a combined $171K — down 20% from $214K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PTPI and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $39.2K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $34K sold.
- 11 institutional investors held Petros Pharmaceuticals (PTPI) as of Q3 2023, down from 12 in Q2 2023.
- Funds reported $171K of Petros Pharmaceuticals stock for Q3 2023, down 20% quarter-over-quarter.
- 2 funds opened new Petros Pharmaceuticals positions in Q3 2023 and 3 closed out, a net change of -1 holder.
- The largest Petros Pharmaceuticals buyer in Q3 2023 was Citadel Advisors, an estimated $39.2K added.
- The largest Petros Pharmaceuticals seller in Q3 2023 was Renaissance Technologies, an estimated $34K sold.
Based on aggregated 13F filings for Q3 2023.